Activity-based protein profiling for biochemical pathway discovery in cancer

Large-scale profiling methods have uncovered numerous gene and protein expression changes that correlate with tumorigenesis. However, determining the relevance of these expression changes and which biochemical pathways they affect has been hindered by our incomplete understanding of the proteome and its myriad functions and modes of regulation. Activity-based profiling platforms enable both the discovery of cancer-relevant enzymes and selective pharmacological probes to perturb and characterize these proteins in tumour cells. When integrated with other large-scale profiling methods, activity-based proteomics can provide insight into the metabolic and signalling pathways that support cancer pathogenesis and illuminate new strategies for disease diagnosis and treatment.

[1]  J. Yates.  Mass spectral analysis in proteomics. , 2004, Annual review of biophysics and biomolecular structure.

[2]  V. Devita,et al.  Trials and tribulations , 2008, Nature Clinical Practice Oncology.

[3]  B. Cravatt,et al.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. , 2008, Annual review of biochemistry.

[4]  S. Chattopadhaya,et al.  Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. , 2004, Journal of the American Chemical Society.

[5]  Nasreen S Jessani,et al.  Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Saghatelian,et al.  Assignment of endogenous substrates to enzymes by global metabolite profiling. , 2004, Biochemistry.

[7]  Matthew Bogyo,et al.  Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes , 2009, Nature Medicine.

[8]  A. Burlingame,et al.  Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.

[9]  Benjamin F. Cravatt,et al.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects , 2008, Nature chemical biology.

[10]  O. Warburg.  On the origin of cancer cells. , 1956, Science.

[11]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[12]  B. Cravatt,et al.  Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes. , 2008, Journal of the American Chemical Society.

[13]  Brent R. Martin,et al.  Large-scale profiling of protein palmitoylation in mammalian cells , 2009, Nature Methods.

[14]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[15]  W. Dai,et al.  Polo-like Kinases Inhibited by Wortmannin , 2007, Journal of Biological Chemistry.

[16]  Nasreen S Jessani,et al.  A streamlined platform for high-content functional proteomics of primary human specimens , 2005, Nature Methods.

[17]  B. Cravatt,et al.  Comparative assessment of large-scale proteomic studies of apoptotic proteolysis. , 2009, ACS chemical biology.

[18]  A. Nadin,et al.  Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. , 2000, Nature.

[19]  Sherry L. Niessen,et al.  Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation* , 2006, Journal of Biological Chemistry.

[20]  Eoin Fahy,et al.  The lipid maps initiative in lipidomics. , 2007, Methods in enzymology.

[21]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[22]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[23]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[24]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[25]  M. Bogyo,et al.  Comparative Assessment of Substrates and Activity Based Probes as Tools for Non-Invasive Optical Imaging of Cysteine Protease Activity , 2009, PloS one.

[26]  L. Foster,et al.  Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products , 2010, Nature Biotechnology.

[27]  Anna E Speers,et al.  Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[28]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[29]  Matthew Bogyo,et al.  Activity-based probes that target diverse cysteine protease families , 2005, Nature chemical biology.

[30]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[31]  Marquis P. Vawter,et al.  The first decade and beyond of transcriptional profiling in schizophrenia , 2012, Neurobiology of Disease.

[32]  D. Tarin,et al.  RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia , 2009, Proceedings of the National Academy of Sciences.

[33]  Sanjai Kumar,et al.  Activity-based probes for protein tyrosine phosphatases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Roos,et al.  Tumorigenicity of cell lines with altered lipid composition. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[36]  M. Bogyo,et al.  Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain. , 2010, ACS chemical biology.

[37]  D. Ferris,et al.  Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. , 2005, Chemistry & biology.

[38]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[39]  R. Aebersold,et al.  Proteomics: the first decade and beyond , 2003, Nature Genetics.

[40]  B. Cravatt,et al.  A suite of activity-based probes for human cytochrome P450 enzymes. , 2009, Journal of the American Chemical Society.

[41]  J. Burbaum,et al.  Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site‐directed probes , 2001, Proteomics.

[42]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[43]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[44]  David T. Barkan,et al.  Global Sequencing of Proteolytic Cleavage Sites in Apoptosis by Specific Labeling of Protein N Termini , 2008, Cell.

[45]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Burk,et al.  On respiratory impairment in cancer cells. , 1956, Science.

[47]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[48]  A. Burlingame,et al.  Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.

[49]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[50]  Dale L Boger,et al.  Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.

[51]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[52]  H. Ploegh,et al.  Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. , 2007, Journal of the American Chemical Society.

[53]  Nasreen S Jessani,et al.  Breast Cancer Cell Lines Grown In Vivo: What Goes in Isn’t Always the Same as What Comes Out , 2005, Cell cycle.

[54]  A. Saghatelian,et al.  Exploring disease through metabolomics. , 2010, ACS chemical biology.

[55]  Helge Weissig,et al.  Functional interrogation of the kinome using nucleotide acyl phosphates. , 2007, Biochemistry.

[56]  H. Höfler,et al.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer , 2005, Breast Cancer Research and Treatment.

[57]  G. Winberg,et al.  Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines , 2006, Molecular carcinogenesis.

[58]  Irwin D Kuntz,et al.  Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. , 2002, Chemistry & biology.

[59]  Benjamin F. Cravatt,et al.  Global Mapping of the Topography and Magnitude of Proteolytic Events in Apoptosis , 2008, Cell.

[60]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[61]  Nasreen S Jessani,et al.  Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Nomura,et al.  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. , 2009, Chemistry & biology.

[63]  Alan Saghatelian,et al.  Untargeted metabolomics. , 2010, Current protocols in molecular biology.

[64]  Alan Saghatelian,et al.  Global strategies to integrate the proteome and metabolome. , 2005, Current opinion in chemical biology.

[65]  Matthew Bogyo,et al.  Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. , 2007, Current pharmaceutical design.

[66]  B. Cravatt,et al.  Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo. , 2007, Chemistry & biology.

[67]  Spencer J. Williams,et al.  Active-site Peptide “Fingerprinting” of Glycosidases in Complex Mixtures by Mass Spectrometry , 2005, Journal of Biological Chemistry.

[68]  B. Cravatt,et al.  Activity-based probes for proteomic profiling of histone deacetylase complexes , 2007, Proceedings of the National Academy of Sciences.

[69]  Steven J Brown,et al.  Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9). , 2010, Bioorganic & medicinal chemistry letters.

[70]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[71]  B. Kemp,et al.  Active site-directed protein regulation , 1999, Nature.

[72]  Carolyn R Bertozzi,et al.  A strategy for functional proteomic analysis of glycosidase activity from cell lysates. , 2004, Angewandte Chemie.

[73]  Xiangdong Li,et al.  Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC/TOF-MS. , 2008, Journal of biomolecular techniques : JBT.

[74]  John R Yates,et al.  Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[76]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[77]  S. Jaffrey,et al.  Global profiling of protease cleavage sites by chemoselective labeling of protein N-termini , 2009, Proceedings of the National Academy of Sciences.

[78]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[79]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[80]  B. Cravatt,et al.  Profiling serine hydrolase activities in complex proteomes. , 2001, Biochemistry.

[81]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[82]  Steven J Brown,et al.  Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes , 2009, Nature Biotechnology.

[83]  F. Snyder,et al.  Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues. , 1969, Cancer research.

[84]  B. Cravatt,et al.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.

[85]  Ruben Abagyan,et al.  A Metabolite Mass Spectral Database , 2005 .

[86]  Anna E Speers,et al.  Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.

[87]  K. Gevaert,et al.  Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis , 2005, Nature Methods.

[88]  E. Schaftingen,et al.  l-2-Hydroxyglutaric aciduria, a disorder of metabolite repair , 2009, Journal of Inherited Metabolic Disease.

[89]  A. Saghatelian,et al.  An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. , 2006, Chemistry & biology.

[90]  S. Ficarro,et al.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[91]  John R. Yates,et al.  The biological impact of mass-spectrometry-based proteomics , 2007, Nature.

[92]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[93]  S. Yao,et al.  Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes. , 2010, Journal of proteome research.

[94]  T. Wandless,et al.  A Cell-permeable, Activity-based Probe for Protein and Lipid Kinases* , 2005, Journal of Biological Chemistry.

[95]  Sherry L. Niessen,et al.  Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.

[96]  B. Cravatt,et al.  Profiling the specific reactivity of the proteome with non-directed activity-based probes. , 2001, Chemistry & biology.

[97]  B. Cravatt,et al.  Disparate proteome reactivity profiles of carbon electrophiles. , 2008, Nature chemical biology.

[98]  Jack Taunton,et al.  A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. , 2007, Nature chemical biology.

[99]  B. Cravatt,et al.  Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study* , 2010, The Journal of Biological Chemistry.

[100]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[101]  W. McGuire,et al.  Cathepsin D and prognosis in breast cancer. , 1990, The New England journal of medicine.

[102]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[103]  Juergen Kast,et al.  PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma. , 2009, Cancer research.